With the increasing use of medical cannabis (MC), there is growing evidence suggesting that MC may be an effective therapeutic for chronic sleep, pain, and a…
Investigating the effectiveness and adverse events of medicinal cannabis for patients with muscle spasticity or spasms.
Appropriate treatment of muscle spasticity and spasms is important as these conditions may significantly impair patients’ quality of life. Conventional pharm…
UK Medical Cannabis Registry: A two-year case series of clinical outcomes in depression.
Whilst preclinical evidence details the effects of cannabinoids on mood regulation, there is a paucity of clinical evidence on the use of cannabis-based medi…
Medical Cannabis Use in France: An Observational Safety Study Based on the RECANN Registry and the Pharmacovigilance/Addictovigilance System From 2021 to 2024.
The French National Agency for Medicines and Health Products Safety implemented in 2021 a nationwide experimentation for medical cannabis (MC), designed to a…
Associations of cannabis use, other substances, and lifestyle choices on anxiety in medical cannabis patients across 45 days.
Previous research has shown medical cannabis (MC) to help reduce anxiety for some individuals, although most studies show trends using cross-sectional design…
Cannabis stigma and symptom management considerations in cancer survivors: a mixed-methods exploration of patient perspectives.
This study aims to assess for indications of stigma and attitudes toward cannabis among cancer survivors (CS) who use or consider the use of cannabis. This s…
Leveraging the national cancer institute’s collaborative efforts to understand the benefits and harms of cannabis use among individuals with cancer.
Cannabis use for symptom management among patients with cancer has increased significantly in recent years, with many reporting benefits for pain, anxiety, s…
Cannabis modalities matter for momentary subjective drug effects.
Modes of cannabis use, or modalities, have been linked to both concurrent and longitudinal outcomes as modes may influence individuals’ subjective experience…
Research Digest: 40 Recent Studies (B) – March 16, 2026
CED Clinical Relevance #85 Research Authority Peer-reviewed research curated for clinical relevance and evidence quality. Recent research digest. 40 of 40 most recent studies from our monitored feeds. CED Clinical Relevance #81...
Cannabis and Dementia Risk: The Truth Behind the Scary Headline
A new study links cannabis-related ER visits to higher dementia risk—but the findings are more about hospital crises than cannabinoids. It’s not about everyday users, and it doesn’t prove causation. Here’s what this paper really tells us—and what it doesn’t.